Tafero EM 30 tabs Emtricitabine + Alafenamide

USD $80.34

Each Tafero EM contains Emtricitabine and Tenofovir Alafenamide with 30 tablets a bottle and is used to treat HIV infection.

ATC Classification: J05AR03
Active Ingrediant: Emtricitabine and Tenofovir Alafenamide
Generic Name: TAFERO EM
Manufacturer: Cipla Limited
Strength: 200/25mg
Dosage Type: Tablet
Packaging Type: Bottle in Box
Contains: 30 Tabs

Examples of Packages sent

Emtricitabine and Tenofovir Alafenamide Information



em trye SYE ta been & ten OF oh vir al a FEN a mide


What is this drug used for?

– It is used to treat HIV infection.

Frequently reported side effects of this drug

– Nausea

– Diarrhea

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

– Infection

– Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain

– Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin

– Lactic acidosis like fast breathing, fast heartbeat, abnormal heartbeat, vomiting, fatigue, shortness of breath, severe loss of strength and energy, or severe dizziness, feeling cold, or muscle pain or cramps

– Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.


Storage and Stability

Store below 30?C (86?F). Dispense in original container.


Adverse Reactions

Also see individual agents.

Central nervous system: Headache

Endocrine & metabolic: Increased serum triglycerides

Gastrointestinal: Abdominal pain, diarrhea, fatigue, nausea

Hepatic: Exacerbation of hepatitis B

Neuromuscular & skeletal: Decreased bone mineral density

Postmarketing: Angioedema, skin rash, urticaria

Additional information

Active Ingrediant

Generic Name

Alternate Names


Dosage Type

Packaging Type